Orrin Hatch actually said...

"As Senator Hatch pointed out, selling into Europe will often face higher taxes and administrative costs than European companies that are selling into the U.S."

"We highlighted the importance of strong market access for U.S. agricultural products."

"I am particularly concerned about the data exclusivity with regard to biologics."

"To the contrary, strong intellectual property protections spur innovation. They are, therefore, essential for providing access to innovative medicines."